Positron emission tomography–computed tomography predictors of progression after DA-R-EPOCH for PMBCL

Chelsea C. Pinnix, Andrea K. Ng, Bouthaina S. Dabaja, Sarah A. Milgrom, Jillian R. Gunther, Clifton D. Fuller, Grace L. Smith, Zeinab Abou Yehia, Wei Qiao, Christine F. Wogan,

Blood Advances · 2018 · 40 citations · 32 references

DOIFull text

Open access

Concepts

Abstract

Key Points Biomarkers are needed to identify patients with PMBCL who will not be cured after single-modality therapy with R-EPOCH. Volume-based and metabolic variables on pre- and postchemotherapy PET-CT seem to identify patients who progress after R-EPOCH alone.

References

32